These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25175457)

  • 21. Cross-receptor interactions between dopamine D2L and neurotensin NTS1 receptors modulate binding affinities of dopaminergics.
    Koschatzky S; Tschammer N; Gmeiner P
    ACS Chem Neurosci; 2011 Jun; 2(6):308-16. PubMed ID: 22778874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Song in an Affiliative Context Relates to the Neural Expression of Dopamine- and Neurotensin-Related Genes in Male European Starlings.
    Merullo DP; Angyal CS; Stevenson SA; Riters LV
    Brain Behav Evol; 2016; 88(2):81-92. PubMed ID: 27614972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similarities in the behavior and molecular deficits in the frontal cortex between the neurotensin receptor subtype 1 knockout mice and chronic phencyclidine-treated mice: relevance to schizophrenia.
    Li Z; Boules M; Williams K; Gordillo A; Li S; Richelson E
    Neurobiol Dis; 2010 Nov; 40(2):467-77. PubMed ID: 20659557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurotensin effects on N-type calcium currents among rat pallidal neurons: an electrophysiological and immunohistochemical study.
    Martorana A; Martella G; D'Angelo V; Fusco FR; Spadoni F; Bernardi G; Stefani A
    Synapse; 2006 Oct; 60(5):371-83. PubMed ID: 16838364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurotensin receptors as modulators of glutamatergic transmission.
    Ferraro L; Tomasini MC; Mazza R; Fuxe K; Fournier J; Tanganelli S; Antonelli T
    Brain Res Rev; 2008 Aug; 58(2):365-73. PubMed ID: 18096238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional role of striatal A2A, D2, and mGlu5 receptor interactions in regulating striatopallidal GABA neuronal transmission.
    Beggiato S; Tomasini MC; Borelli AC; Borroto-Escuela DO; Fuxe K; Antonelli T; Tanganelli S; Ferraro L
    J Neurochem; 2016 Jul; 138(2):254-64. PubMed ID: 27127992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotensin(8-13) analogs as dual NTS1 and NTS2 receptor ligands with enhanced effects on a mouse model of Parkinson's disease.
    Kühl T; Georgieva MG; Hübner H; Lazarova M; Vogel M; Haas B; Peeva MI; Balacheva AA; Bogdanov IP; Milella L; Ponticelli M; Garev T; Faraone I; Detcheva R; Minchev B; Petkova-Kirova P; Tancheva L; Kalfin R; Atanasov AG; Antonov L; Pajpanova TI; Kirilov K; Gastreich M; Gmeiner P; Imhof D; Tzvetkov NT
    Eur J Med Chem; 2023 Jun; 254():115386. PubMed ID: 37094450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum.
    Fuxe K; O'Connor WT; Antonelli T; Osborne PG; Tanganelli S; Agnati LF; Ungerstedt U
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5591-5. PubMed ID: 1535159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in [
    Rosin C; López Ordieres MG; Rodríguez de Lores Arnaiz G
    Peptides; 2017 Mar; 89():82-89. PubMed ID: 27586561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Striatal dopamine receptor plasticity in neurotensin deficient mice.
    Chastain LG; Qu H; Bourke CH; Iuvone PM; Dobner PR; Nemeroff CB; Kinkead B
    Behav Brain Res; 2015 Mar; 280():160-71. PubMed ID: 25449842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease.
    Fuxe K; Agnati LF; Jacobsen K; Hillion J; Canals M; Torvinen M; Tinner-Staines B; Staines W; Rosin D; Terasmaa A; Popoli P; Leo G; Vergoni V; Lluis C; Ciruela F; Franco R; Ferré S
    Neurology; 2003 Dec; 61(11 Suppl 6):S19-23. PubMed ID: 14663004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine D2 heteroreceptor complexes and their receptor-receptor interactions in ventral striatum: novel targets for antipsychotic drugs.
    Fuxe K; Borroto-Escuela DO; Tarakanov AO; Romero-Fernandez W; Ferraro L; Tanganelli S; Perez-Alea M; Di Palma M; Agnati LF
    Prog Brain Res; 2014; 211():113-39. PubMed ID: 24968778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essential Control of the Function of the Striatopallidal Neuron by Pre-coupled Complexes of Adenosine A
    Ferré S; Bonaventura J; Zhu W; Hatcher-Solis C; Taura J; Quiroz C; Cai NS; Moreno E; Casadó-Anguera V; Kravitz AV; Thompson KR; Tomasi DG; Navarro G; Cordomí A; Pardo L; Lluís C; Dessauer CW; Volkow ND; Casadó V; Ciruela F; Logothetis DE; Zwilling D
    Front Pharmacol; 2018; 9():243. PubMed ID: 29686613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotensin enhances glutamatergic EPSCs in VTA neurons by acting on different neurotensin receptors.
    Bose P; Rompré PP; Warren RA
    Peptides; 2015 Nov; 73():43-50. PubMed ID: 26296323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotensin speeds inhibition of dopamine neurons through temporal modulation of GABA
    Tschumi CW; Beckstead MJ
    Neuropharmacology; 2018 Mar; 131():414-423. PubMed ID: 29307543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of intraamygdaloid neurotensin and dopamine interaction in conditioned place preference.
    László K; Péczely L; Kovács A; Zagoracz O; Ollmann T; Kertes E; Kállai V; Csetényi B; Karádi Z; Lénárd L
    Behav Brain Res; 2018 May; 344():85-90. PubMed ID: 29462652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
    Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of neurotensin receptor type 1 attenuates locomotor activity.
    Vadnie CA; Hinton DJ; Choi S; Choi Y; Ruby CL; Oliveros A; Prieto ML; Park JH; Choi DS
    Neuropharmacology; 2014 Oct; 85():482-92. PubMed ID: 24929110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesolimbic dopamine and cortico-accumbens glutamate afferents as major targets for the regulation of the ventral striato-pallidal GABA pathways by neurotensin peptides.
    Ferraro L; Tomasini MC; Fuxe K; Agnati LF; Mazza R; Tanganelli S; Antonelli T
    Brain Res Rev; 2007 Aug; 55(1):144-54. PubMed ID: 17448541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strong effects of NT/NN peptides on DA D2 receptors in rat neostriatal sections.
    Li XM; Hedlund PB; Fuxe K
    Neuroreport; 1994 Aug; 5(13):1621-4. PubMed ID: 7819533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.